Cardiac Arrhythmias 1995: Proceedings of the 4th International Workshop on Cardiac Arrhythmias (Venice, 6–8 October 1995)

Front Matter....Pages II-VIII
Front Matter....Pages 1-1
Non-sustained Ventricular Tachycardia: Is It Possible to Identify the High-Risk Patients and How to Treat Them?....Pages 3-5
QT Prolongation in Postinfarction Patients and Sudden Death: Which Relationship?....Pages 6-11
T wave Alternans. A Marker of Vulnerability to Ventricular Tachyarrhythmias....Pages 12-16
Idiopathic Ventricular Fibrillation: Which Prognosis and Treatment?....Pages 17-22
Beta Blockers, Sotalol, or Amiodarone for the Treatment of Malignant Ventricular Arrhythmias?....Pages 23-30
New Antiarrhythmic Drugs for Ventricular Arrhythmias: Do They Work....Pages 31-38
What Have We Learned from the SWORD Trial? Can Potassium Channel Blockers Reduce Sudden Cardiac Death?....Pages 39-42
To Treat or Not To Treat Ventricular Arrhythmias in Dilated Cardiomyopathy?....Pages 43-49
Which Therapeutic Approach for Patients with Hypertrophic Cardiomyopathy and Ventricular Arrhythmias?....Pages 50-54
Radiofrequency Catheter Ablation of Ventricular Tachycardia in Patients with Structural Heart Disease: Pathophysiologic Considerations to Simplify the Selection of the Target Sites....Pages 55-64
Front Matter....Pages 65-65
Is Total Mortality Really Reduced by the Implantable Cardioverter Defibrillator?....Pages 67-70
What Are the Acute and Long-Term Results of Transvenous Implantable Cardioverter Defibrillators?....Pages 71-74
How To Prevent or Avoid Inappropriate Implantable Cardioverter Defibrillator Shocks?....Pages 75-80
What Have We Learned from Stored Implantable Cardioverter Defibrillator Electrocardiograms about the Mechanism of Sudden Death?....Pages 81-85
Implantable Cardioverter Defibrillator: A Therapy for Everyone or for Selected Patients?....Pages 86-90
Implantable Cardioverter Defibrillator Technology in the Next 10 Years: What Can Be Expected?....Pages 91-95
Front Matter....Pages 97-97
Spontaneous Asystolic Pauses: How Frequent Is a Neuromediated Mechanism?....Pages 99-101
Pathophysiology of Neurally Mediated Syncope: Peripheral and Central Mechanisms....Pages 102-109
Syncope of Unknown Origin: First Head-Up Tilt Test or Electrophysiologic Study?....Pages 110-115
Methodology of Head-Up Tilt Test: What is the Sensitivity and Specificity of the Different Protocols?....Pages 116-121
Front Matter....Pages 97-97
What Do We Know Today About the Outcome of Vasovagal Syncope?....Pages 122-126
Vasovagal Syncope with Asystolic Pause: Drugs, Pacemaker, or Both?....Pages 127-131
Invasive Tilt Testing: The Search for a New Sensor To Permit Earlier Pacing Therapy in Vasovagal Syncope....Pages 132-133
Front Matter....Pages 135-135
Isolated First-Degree Atrioventricular Block: A New Indication for Dual-Chamber Pacing?....Pages 137-139
Physiologic Dual-Chamber Pacing with Short Atrioventricular Delay in Dilated Cardiomyopathy: Which Hemodynamic Effects and Clinical Results?....Pages 140-143
Dual-Chamber Pacing in Obstructive Hypertrophic Cardiomyopathy: Is There Evidence for a Real Benefit?....Pages 144-146
Automatic Mode Switching: How Useful Is It?....Pages 147-150
Extraction of Chronically Implanted Pacemaker Leads: When and How?....Pages 151-158
Front Matter....Pages 159-159
Transesophageal Pacing During Exercise: Is It Useful to Evaluate Palpitations of Unknown Origin?....Pages 161-165
New Approaches to Treatment of Atrial Tachycardia....Pages 166-171
Atrioventricular Node Anatomy and Physiology: What Have We Learned from Catheter Ablation?....Pages 172-175
Radiofrequency Ablation of Atrioventricular Node Reentrant Tachycardias: Which Results and Predictors of Success and Recurrence?....Pages 176-180
Surface Electrocardiogram in Ventricular Pre-excitation: How Reliable Is It To Locate the Site of Accessory Pathway?....Pages 181-182
Radiofrequency Ablation in the Wolff-Parkinson-White Syndrome: Do the Results Justify a Widespread Application?....Pages 183-186
Recurrent Palpitations After Successful Radiofrequency Ablation of Supraventricular Tachycardias: Which Significance?....Pages 187-189
Antiarrhythmic Therapy of Supraventricular Tachyarrhythmias: Which Role for the Drugs Today?....Pages 190-191
Radiofrequency Ablation of Supraventricular Tachycardias in Infants and Children: When Is It Really Indicated?....Pages 192-196
Front Matter....Pages 197-197
Lone Atrial Fibrillation: Which Anatomical and Electrophysiologic Substrate?....Pages 199-202
Is Mortality in Patients with Atrial Fibrillation Related to the Underlying Heart Disease or to the Arrhythmia?....Pages 203-206
Thromboembolic Risk in Patients with Atrial Fibrillation: Can It Be Predicted on the Basis of Clinical Variables?....Pages 207-211
Front Matter....Pages 197-197
Should All Patients Undergo Transesophageal Echocardiography Before Electrical Cardioversion of Atrial Fibrillation....Pages 212-215
Anticoagulation in Atrial Fibrillation: Is Aspirin Sufficient?....Pages 216-220
Pharmacologic Cardioversion of Atrial Fibrillation: Always the Same Algorithm or Different Drugs for Different Patients?....Pages 221-224
Prophylaxis of Atrial Fibrillation: What are the Benefits and Risks of the Different Antiarrhythmic Drugs?....Pages 225-230
Atrial Fibrillation with a Slow Ventricular Response: Is Theophylline a Good Alternative to a Pacemaker?....Pages 231-235
Control of Rapid Heart Rate in Patients with Atrial Fibrillation: Drugs or Ablation?....Pages 236-241
How Effective and Safe Is Internal Direct Current Shock for Atrial Fibrillation Refractory to External Cardioversion?....Pages 242-245
Automatic Implantable Atrial Defibrillator: A Dream or a Real Prospect?....Pages 246-248
Paroxysmal Atrial Flutter: Which Mechanism and Treatment in the Era of Catheter Ablation?....Pages 249-254
Back Matter....Pages 255-255